ReWalk (RWLK) makes an FDA-approved exoskeleton that enables disabled people, even those mostly paralyzed, to walk upright. Exoskeletons have been a hotbed of research and development over the last decade and they are now entering commercialization.
It’s still very early in the adoption cycle because these devices are new and expensive. The ReWalk, for example, is $70K. But exoskeleton technology in general, and the ReWalk in particular, are in the process of coming of age for military, medical, and ultimately for more utilitarian purposes.
ReWalk . . .